Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients
Systemic anticoagulation may be associated with improved outcomes among patients hospitalized with COVID-19, according to a research letter published May 6, 2020, in the Journal of the American College of Cardiology. Researchers analyzed the association between in-hospital anticoagulation administration and mortality among 2,773 patients hospitalized with COVID-19.